Product Program year 2025 Source: CMS Open Payments

Infuse Multifocal

Device Ophthalmology

Open in the dashboard

General payments

$547,443

1,739 payments

Research payments

$0

0 payments

Through program year 2025, $547,443 in general payments and $0 in research payments were reported against Infuse Multifocal (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $257,885 883
2024 General $289,558 856

Breakdown

Who paid General payments · program years 2024–2025
  1. Bausch & Lomb Americas Inc. $547,443 1,739 payments
Top recipients General payments · program year 2025
  1. John Womack Optometrist · Canton, GA $29,529 11% · 49 payments
  2. Jason Tu Optometrist · San Diego, CA $22,487 9% · 44 payments
  3. Scott Moscow Optometrist · Roswell, GA $17,523 7% · 43 payments
  4. Osama Said Optometrist · Raleigh, NC $16,951 7% · 32 payments
  5. Brad Laudicina Optometrist · Bradenton, FL $15,096 6% · 38 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Optometrist $255,320 99% · 480 practitioners
  2. Optometrist, Corneal and Contact Management Optometrist $1,286 <1% · 10 practitioners
  3. Ophthalmology $643 <1% · 5 practitioners
  4. Optometrist, Vision Therapy Optometrist $272 <1% · 2 practitioners
  5. Optometrist, Low Vision Rehabilitation Optometrist $124 <1% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $62,438 24% · 26 recipients
  2. California $50,813 20% · 41 recipients
  3. North Carolina $25,160 10% · 41 recipients
  4. Georgia $20,246 8% · 23 recipients
  5. Texas $19,712 8% · 15 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,739 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record